Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Recalled by Allergan Inc Due to Allergan is recalling the NATRELLE 133 and CUI...

Date: June 18, 2015
Company: Allergan Inc
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Allergan Inc directly.

Affected Products

Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is intended for temporary subcutaneous implantation and require periodic, incremental inflation with sterile saline for injection until the desired amount of tissue is developed.

Quantity: 167 units total (114 units in US)

Why Was This Recalled?

Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the product shipped was beyond the 47 month shelf life.

Where Was This Sold?

US in the state of Canada

About Allergan Inc

Allergan Inc has 3 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report